Overview
Fred Etoc serves as Chief Scientific Officer at Rumi Scientific [1][3]. Etoc's research background spans biology and biotechnologies, including a PhD from Institut Curie focused on the intersection of nanotechnology and cell biology [5][2]. Following doctoral work, Etoc completed a postdoctoral position at Rockefeller University from 2013 to 2017, where research centered on developing models of human development using human embryonic stem cells and creating tools for studying human embryology and disease pathogenesis [4][2]. Etoc holds a Master's degree in Biophysics from École normale supérieure [6]. The work conducted during postdoctoral research has been adapted toward drug discovery applications for neurological disorders in Etoc's current role [2].
Profile introduction
Multi-disciplinary researcher in biology/biotechnologies. After a PhD at the intersection between nanotechnology and cell biology, I did a postdoc at the Rockefeller University focused on building models of human development starting from human embryonic stem cells. This led to the creation of a new set of innovative tools for the study of human embryology and disease pathogenesis. I am now adapting these discoveries towards drug discovery for neurological disorders as the CSO of RUMI Scientific.
Career history
- Chief Scientific OfficerOct 2017 to presentRumi Scientific
- Postdoctoral ResearcherSep 2013 to Oct 2017The Rockefeller University
- PHDSep 2009 to Sep 2013Institut Curie
Education
- Master's degree, Biophysics at Ecole normale supérieure2006 - 2009Education
This page shows public professional information only, each fact cited. Is this you? send a correction, or ask for removal within 24 hours, no questions asked.